Artegraft Collagen Vascular Graft; REF: AG1015; Recall
Artegraft¿ Collagen Vascular Graft; REF: AG1015;
FDA recall Class II
Ongoing
FDA lists this Class II recall for Artegraft Collagen Vascular Graft; REF: AG1015;. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0289-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Sep 25, 2025
- FDA report date
- Oct 29, 2025
- Quantity in commerce
- 1 unit
- Distribution
- See key details
- FDA cause
- Packaging change control
What is being recalled?
Artegraft Collagen Vascular Graft; REF: AG1015;
Affected model & UDI checker
Search the exact identifiers published for Z-0289-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| AG1015 | Artegraft Collagen Vascular Graft; REF: AG1015; | Check source notice | Not specified |
| Not specified | Artegraft Collagen Vascular Graft; REF: AG1015; | Check source notice | 00316837000343 |
FDA code information
REF: AG1015; UDI-DI: 00316837000343; Lot/Serial Number: 23MM581-016;
Why was this product recalled?
The device was incorrectly packed in the wrong size labeled outer packaging.
What actions did LeMaitre Vascular, Inc. take?
On September 25, 2025, an "URGENT: MEDICAL DEVICE RECALL" letter was sent to the customer. Actions to be taken: Check your inventory against the list of lots in this letter. Immediately quarantine any recalled devices. Complete and return the form provided even if you have no devices in inventory. If the product has been implanted, graft explantation/patient intervention is NOT required. Scan the reply form and send it to [email protected]. When a recalled device has been returned to LeMaitre Vascular, a replacement device will be provided. If you have transferred devices to another facility, please forward a copy of this recall letter to them. If you have any questions, contact Sr. Director, Quality Affairs, via email: [email protected] or at 732-422-8333 Monday through Friday, 8:00AM to 4:30 PM, Eastern Time.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0289-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology